Form 4: Emergent BioSolutions Director Donald W. DeGolyer Reports Acquisition of Shares and Stock Options

Director Donald W. DeGolyer reports the acquisition of common stock and stock options in Emergent BioSolutions Inc. on April 30, 2025.

Summary

• Donald W. DeGolyer, a director of Emergent BioSolutions Inc., filed a Form 4 on May 2, 2025, reporting changes in beneficial ownership.
• On April 30, 2025, DeGolyer acquired 34,403 shares of common stock through a restricted stock unit (RSU) grant and disposed of 145,503 shares.
• He also acquired 15,824 stock options with an exercise price of $5.45, exercisable from April 29, 2032.
• The RSUs and stock options were granted under the company's Stock Incentive Plan for Board and Committee service and vest on the day prior to the one-year anniversary of the grant date, contingent on continued board membership.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting requirements incentivize continued service on the board of directors.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies to align the interests of directors and management with shareholders.

Stakeholder Impact

• The grant of stock options and RSUs aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.

Key Dates

Keywords

Emergent BioSolutions, Form 4, Director, DeGolyer, Stock Options, RSU, Beneficial Ownership, Incentive Plan